Background: Bronchoscopic lung volume reduction (BLVR) has been applied in COPD patients with
Introduction
Chronic obstructive pulmonary disease (COPD) has been a major public health problem in Vietnam. The first national epidemiological study undertaken based on questionnaires and lung functional testing, estimated the prevalence of COPD in 2010 to be 4,2% in a sample population of subjects aged over 40 years (about 1.300.000 COPD patients): 7.1% of male and 1.9% of 
Method:
Study Design: Characteristics of patients are shown in the (Table 3) The change of lung function was assessed at 3 months (Table 3) The change of Raw at 3 months was not statistically significant. (Table 4) The median post-procedure stay was 5 days Blocked valve because of mucus 3 10.00
Granulation around the valve 2 6.67 complications were similar our results, however, the portion of valve removal in these studies was more than in our 15, 16 . In general, the technique of bronchial valve placement via flexible bronchoscopy is acceptable safe, with the mild complications.
Conclusion
The unilateral bronchoscopic lung volume reduction with one-way valve (mainly one valve) in treatment of heterogeneous severe emphysema in stable COPD patients in Viet Nam have shown that this procedure is safe with encouraging initial results (increased lightly exercise capacity exercise capacity and FVC, decreased lightly the degree of dyspnea, RV and TLC at 3 months).
